Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
Public ClinicalTrials.gov record NCT02937701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Phase 3 Study to Assess the Efficacy and Safety of ABP 710 Compared to Infliximab in Subjects With Moderate to Severe Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of the study was to compare rheumatoid arthritis symptom improvement in participants who were given ABP 710 to those who were given infliximab, 22 weeks after starting treatment.
Study identification
- NCT ID
- NCT02937701
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 558 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 10, 2016 (Actual)
- Primary completion
- Apr 16, 2018 (Actual)
- Completion
- Aug 13, 2018 (Actual)
- Last update posted
- Aug 28, 2019
2016 – 2018
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | Tuscaloosa | Alabama | 35406 | — |
| Research Site | Peoria | Arizona | 85381 | — |
| Research Site | Covina | California | 91722 | — |
| Research Site | Hemet | California | 92543-4403 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Van Nuys | California | 91405 | — |
| Research Site | Aventura | Florida | 33180 | — |
| Research Site | Miami Lakes | Florida | 33014 | — |
| Research Site | Orlando | Florida | 32804 | — |
| Research Site | Sarasota | Florida | 34239 | — |
| Research Site | Vero Beach | Florida | 32960 | — |
| Research Site | Lexington | Kentucky | 40504 | — |
| Research Site | Grand Blanc | Michigan | 48439 | — |
| Research Site | Flowood | Mississippi | 39232 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Omaha | Nebraska | 68114 | — |
| Research Site | Voorhees Township | New Jersey | 08043 | — |
| Research Site | Charlotte | North Carolina | 28210 | — |
| Research Site | Charleston | South Carolina | 29406-9333 | — |
| Research Site | Memphis | Tennessee | 38119 | — |
| Research Site | Carrollton | Texas | 75007-1601 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Houston | Texas | 77429-5890 | — |
| Research Site | League City | Texas | 77573 | — |
| Research Site | Plano | Texas | 75024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02937701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2019 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02937701 live on ClinicalTrials.gov.